Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-060538

EVP, Research & CSO sold 2,340 shares at $27.29 ($63,848)

  • EVP, Research & CSO acquired 2,340 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-24 Exercise or conversion : show line 1 in the form +2,340 $1.53 $3,580 26,040 D
2020-11-24 Sale : show line 2 in the form −2,340 $27.29 $63,848 23,700 D
Open-market sales · 2,340 sh · avg $27.29 · $63,848

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-24 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −2,340 445,830 D
Loading xslF345X03/doc4.xml…